Hycamtin (Hy-CAM-tin, topotecan) for ovarian cancer

July 1996

SmithKline Beecham is introducing Hycamtin (Hy-CAM-tin, topotecan) for ovarian cancer.

Hycamtin is the first in a new class called camptothecins...or topoisomerase I inhibitors. Blocking this enzyme leads to DNA damage when cells replicate.

Hycamtin will be used as second-line therapy for advanced ovarian cancer...usually after treatment with cisplatin or Taxol.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote